studies have been carried out on monoclonal gammopathy of unknown significances (MGUS), smoldering multiple myeloma (SMM), and multiple myeloma (MM), their classification and underlying pathogenesis are far from…
Multiple Myeloma (MM) cancer has been and continues to be the subject of many research studies. The main goal is to improve the therapeutic/treatment process of the survival ... data-driven statistical model for the…
initiated. With the constellation of renal insufficiency stage III along with macrocytic anemia, multiple myeloma was suspected by the medicine team. Serum protein electrophoresis showed M protein ... calcium level as…
According to WHO 2016, multiple myeloma is a hematologic malignancy, usually in the bone marrow with an increase of more than 10% of plasma cells, with morphological identifications, immunological markers ... rouleaux…
Statement of the Problem: The heterogeneous subsets in hematological malignancy such as multiple myeloma may be better characterize when tumor profiling were performed in multiple different dimensions. An integrative…
Backround: Multiple myeloma (MM) and the associated immunomodulatory (IMiD)treatments are associated with risk of vascular complications. Thrombin generation (TG) assessment reflects the equilibrium between procoagulant…
Advanced imaging modalities are being increasingly utilized for initial evaluation in patients with multiple myeloma. Whole body magnetic resonance imaging (WB-MRI) is far superior to standard metastatic bone survey…
Background: Multiple myeloma is characterized by neoplastic proliferation of a single clone of plasma cells producing a monoclonal immunoglobulin. It comprises about 1% of all malignant tumours ... haematopoietic…
represents 10% of hematological malignancies. 50% of patients with renal impairment. Renal involvement in myeloma is normal; it entangles the management of patients and sometimes worsens the prognosis. The objective…
malignancy, and certain immunomodulatory medication. PML has been reported only rarely in multiple myeloma (MM) patients. We describe a rare case of PML with immune reconstitution inflammatory syndrome (IRIS ... patient…
Introduction: Multiple myeloma (MM) is a clonal plasma cell proliferative disorder that accounts for 1% of all malignancies and 10% of malignant hematologic neoplasms. Plasmablastic MM is a morphologic subset…
important role in epigenetic regulation, which could be involved in pathogenesis of multiple myeloma (MM). Active DNA demethylation occurs during 5-methylcytosine through TET (Ten Eleven Translocation) enzyme-mediated…
Introduction: Multiple myeloma is the most common bone malignancy characterized by malignant proliferation of plasma cells leading to production of a monoclonal paraprotein. Varied clinical presentations are noted…
Multiple myeloma may be a malignant lymph cell disorder that accounts for about 100% of all medicine cancers. It’s characterised by accumulation of organism plasma cells, preponderantly within ... thus, it's expected…
Abstract: The aim of this audit is to evaluate whether MRI acquisition in Multiple Myeloma patients includes Diffusion weighted imaging and ADC mapping according to the guidelines established by Myeloma ... Response…
help you battle contaminations by making antibodies that perceive and assault germs. In various myeloma, carcinogenic plasma cells aggregate in the bone marrow and group out sound platelets. While there ... solution for…
Background: Risk stratification in Multiple Myeloma is typically done based on a set of chromosomal abnormalities including translocations and deletions and karyotype abnormalities such as hypodiploidy and…
outcome of patients with multiple myeloma has improved in the past decade as a result of novel therapeutic agents such as immunomodulatory drugs, proteasome inhibitors, monoclonal antibodies, and autologous stem…
BACKGROUND Multiple myeloma is also called as plasma cell myeloma or myelomatosis. It is a malignant clonal proliferation of neoplastic plasma cells within the bone marrow. Its incidence increases with ... Multiple…
Abstract: Background and objectives: Multiple myeloma is a complex neoplastic plasma cell disorder which necessitates a high index of suspicion and a rational approach to diagnosis. The diagnosis requires meeting…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.